Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 3
1981 3
1982 4
1983 3
1984 4
1985 3
1986 8
1987 4
1988 6
1989 11
1990 11
1991 7
1992 15
1993 23
1994 26
1995 8
1996 26
1997 14
1998 18
1999 18
2000 13
2001 12
2002 18
2003 22
2004 16
2005 20
2006 19
2007 20
2008 9
2009 13
2010 14
2011 13
2012 7
2013 10
2014 8
2015 8
2016 10
2017 6
2018 4
2019 5
2020 6
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

444 results
Results by year
Filters applied: . Clear all
Page 1
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pavel M, Öberg K, Falconi M, Krenning EP, Sundin A, Perren A, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Pavel M, et al. Among authors: krenning ep. Ann Oncol. 2020 Jul;31(7):844-860. doi: 10.1016/j.annonc.2020.03.304. Epub 2020 Apr 6. Ann Oncol. 2020. PMID: 32272208 No abstract available.
Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.
Brabander T, van der Zwan WA, Teunissen JJM, Kam BLR, Feelders RA, de Herder WW, van Eijck CHJ, Franssen GJH, Krenning EP, Kwekkeboom DJ. Brabander T, et al. Among authors: krenning ep. Clin Cancer Res. 2017 Aug 15;23(16):4617-4624. doi: 10.1158/1078-0432.CCR-16-2743. Epub 2017 Apr 20. Clin Cancer Res. 2017. PMID: 28428192 Free article.
Gastroenteropancreatic neuroendocrine tumours.
Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Modlin IM, et al. Among authors: krenning ep. Lancet Oncol. 2008 Jan;9(1):61-72. doi: 10.1016/S1470-2045(07)70410-2. Lancet Oncol. 2008. PMID: 18177818 Review.
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy.
Bodei L, Kidd MS, Singh A, van der Zwan WA, Severi S, Drozdov IA, Cwikla J, Baum RP, Kwekkeboom DJ, Paganelli G, Krenning EP, Modlin IM. Bodei L, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1155-1169. doi: 10.1007/s00259-018-3967-6. Epub 2018 Feb 26. Eur J Nucl Med Mol Imaging. 2018. PMID: 29484451 Free PMC article.
Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours.
van der Zwan WA, Brabander T, Kam BLR, Teunissen JJM, Feelders RA, Hofland J, Krenning EP, de Herder WW. van der Zwan WA, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):704-717. doi: 10.1007/s00259-018-4158-1. Epub 2018 Sep 28. Eur J Nucl Med Mol Imaging. 2019. PMID: 30267116 Free PMC article.
In memoriam: Dirk J Kwekkeboom (1958-2017).
de Herder WW, Krenning EP, Krestin GP. de Herder WW, et al. Among authors: krenning ep. Endocr Relat Cancer. 2017 May 1;24(5):E1-E2. doi: 10.1530/ERC-17-0087. Endocr Relat Cancer. 2017. PMID: 30390609 No abstract available.
Octreoscan radioreceptor imaging.
van der Lely AJ, de Herder WW, Krenning EP, Kwekkeboom DJ. van der Lely AJ, et al. Among authors: krenning ep. Endocrine. 2003 Apr;20(3):307-11. doi: 10.1385/ENDO:20:3:307. Endocrine. 2003. PMID: 12721512 Review.
Somatostatin receptor imaging.
Kwekkeboom DJ, Krenning EP. Kwekkeboom DJ, et al. Among authors: krenning ep. Semin Nucl Med. 2002 Apr;32(2):84-91. doi: 10.1053/snuc.2002.31022. Semin Nucl Med. 2002. PMID: 11965603 Review.
444 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page